Evidence map›Paper›PMID 26048637›Full record

Trial reportDrug and alcohol dependence2015

A single dose of kudzu extract reduces alcohol consumption in a binge drinking paradigm.

David M Penetar, Lindsay H Toto, David Y-W Lee, Scott E Lukas

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Differential Influence ofPharmaceuticals (Basel, Switzerland) · 2021
    Article
  10. Article
  11. Article
  12. Plants with Anti-Addictive Potential.Advances in experimental medicine and biology · 2021
    Article
  13. Applications ofChinese herbal medicines · 2019
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

David M PenetarBehavioral Psychopharmacology Research Laboratory, McLean Hospital, Belmont, MA 02478, USA; Department of Psychiatry, Harvard Medical School, Boston, MA 02115, USA. Electronic address: dpenetar@mclean.harvard.edu.
Lindsay H TotoBehavioral Psychopharmacology Research Laboratory, McLean Hospital, Belmont, MA 02478, USA. Electronic address: Lindsay.Toto@childrens.harvard.edu.
David Y-W LeeDepartment of Psychiatry, Harvard Medical School, Boston, MA 02115, USA; Department of Bio-Organic and Natural Products Laboratory, McLean Hospital, Belmont, MA 02478, USA; Natural Pharmacia International, Inc, Burlington, MA 01803, USA. Electronic address: dlee@mclean.harvard.edu.
Scott E LukasBehavioral Psychopharmacology Research Laboratory, McLean Hospital, Belmont, MA 02478, USA; Department of Psychiatry, Harvard Medical School, Boston, MA 02115, USA. Electronic address: slukas@mclean.harvard.edu.
Harvard University · USMcLean Hospital · US

Funding

Project 4 - Chinese Herbal Medicine to Treat Alcohol &Drug AbuseP01AT002038 · NCCIH · MC LEAN HOSPITAL (BELMONT, MA) · PI LEE, DAVID YUE-WEI · 2004 to 2008
$5.8M
ISOFLAVONE TREATMENT FOR ALCOHOL ABUSER01AA010536 · NIAAA · MC LEAN HOSPITAL (BELMONT, MA) · PI LUKAS, SCOTT E · 1996 to 2011
$5.0M
NCCIH NIH HHS P01 AT002038NCCIH NIH HHS P01-AT002038NIAAA NIH HHS R01 AA010536NIAAA NIH HHS R01 AA10536
6 · The paper itself

Abstract

backgroundOverconsumption of alcohol has significant negative effects on an individual's health and contributes to an enormous economic impact on society as a whole. Pharmacotherapies to curb excessive drinking are important for treating alcohol use disorders.

methodsTwenty (20) men participated in a placebo-controlled, double-blind, between subjects design experiment (n=10/group) that tested the effects of kudzu extract (Alkontrol-Herbal™) for its ability to alter alcohol consumption in a natural settings laboratory. A single dose of kudzu extract (2g total with an active isoflavone content of 520mg) or placebo was administered 2.5h before the onset of a 90min afternoon drinking session during which participants had the opportunity to drink up to 6 beers ad libitum; water and juice were always available as alternative beverages.

resultsDuring the baseline session, the placebo-randomized group consumed 2.7±0.78 beers before treatment and increased consumption to 3.4±1.1 beers after treatment. The kudzu group significantly reduced consumption from 3.0±1.7 at baseline to 1.9±1.3 beers after treatment. The placebo-treated group opened 33 beers during baseline conditions and 38 following treatment whereas the kudzu-treated group opened 32 beers during baseline conditions and only 21 following treatment. Additionally, kudzu-treated participants drank slower.

conclusionThis is the first demonstration that a single dose of kudzu extract quickly reduces alcohol consumption in a binge drinking paradigm. These data add to the mounting clinical evidence that kudzu extract may be a safe and effective adjunctive pharmacotherapy for alcohol abuse and dependence.

Indexed as

PhytotherapyAdultAlcohol DrinkingBeerBinge DrinkingDouble-Blind MethodHumansIsoflavonesMalePlant ExtractsPuerariaYoung AdultIsoflavonesPlant ExtractsAlcoholBinge drinkingIsoflavoneKudzuThe study was registered with ClinicalTrials.gov (NTC no. 01596231)

Identifiers

PMID26048637
PMCPMC4510012
OpenAlexW1528288958

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.